Answer
Uniphyllin prolonged-release tablets (theophylline hydrate) treat and prevent bronchospasm associated with asthma, chronic obstructive pulmonary disease and chronic bronchitis, and treat left ventricular and congestive cardiac failure in adults and children aged 6 years and above; theophylline should not be first-choice asthma treatment in children.
Sources for this answer
- Uniphyllin 200 mg prolonged-release tabletsEnnogen IP Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 2Document updated
Sources checked